Genentech eyes Dec. 20 FDA decision date for new leukemia drug
July 03, 2013 at 14:03 PM EDT
Genentech Inc. could get an FDA decision by Dec. 20 on a new leukemia drug as the clock winds down on patent protection for its blockbuster Rituxan...
